Merker M P, Handschumacher R E
J Immunol. 1984 Jun;132(6):3064-70.
In a survey of malignant cell lines including a variety of leukemias and lymphomas, BW5147, a T lymphoma from the spontaneous virus-associated thymoma in AKR mice, was found to be the most sensitive to growth inhibition by cyclosporin A (Cs A). Inhibition of growth was cell cycle phase-independent and inhibition of macromolecular precursor uptake was relatively nonspecific. Uptake of radiolabeled Cs A by these cells was characterized by two components: one that appeared saturable at low drug concentrations (0.03 to 1.0 microgram/ml), and another that was nonsaturable at higher drug concentrations (1.0 microgram/ml or higher). Most of the drug concentrated by cells (70 to 80%) was located in the cytosol (100,000 X G supernatant of lysed cells). The apparent m.w. of the drug-macromolecule complex was 15,000 to 20,000 as determined by m.w. exclusion columns. This complex could also be formed by adding drug to cytosol prepared from unexposed cells. The low m.w. complex migrated on a preparative isoelectric focusing column to form two peaks with isoelectric points of 6.8 and 8.5. A method was developed to assay for the binding component, and a sequence of m.w. exclusion columns and isoelectric focusing was used to effect partial purification of the Cs A binding component.
在一项对包括多种白血病和淋巴瘤在内的恶性细胞系的调查中,发现BW5147(一种源自AKR小鼠自发性病毒相关胸腺瘤的T淋巴瘤)对环孢菌素A(Cs A)的生长抑制最为敏感。生长抑制与细胞周期阶段无关,对大分子前体摄取的抑制相对非特异性。这些细胞对放射性标记的Cs A的摄取具有两个成分:一个在低药物浓度(0.03至1.0微克/毫升)时表现出饱和性,另一个在较高药物浓度(1.0微克/毫升或更高)时不饱和。细胞浓缩的大部分药物(70%至80%)位于胞质溶胶中(裂解细胞的100,000×G上清液)。通过分子量排阻柱测定,药物 - 大分子复合物的表观分子量为15,000至20,000。通过向未接触药物的细胞制备的胞质溶胶中添加药物,也可以形成这种复合物。低分子量复合物在制备性等电聚焦柱上迁移形成两个峰,等电点分别为6.8和8.5。开发了一种测定结合成分的方法,并使用一系列分子量排阻柱和等电聚焦来实现Cs A结合成分的部分纯化。